|
|
||||||||
Departments of 1 Clinical Investigation and 2 Pediatrics, Tripler Army Medical Center, Honolulu 96859; 5 Department of Pediatrics and 4 Pathology, Kapi'olani Medical Center for Women and Children, John A. Burns School of Medicine, and 3 Department of Medicine, University of Hawaii, Honolulu, Hawaii 96826
This study tested the
hypothesis that inhaled nitric oxide (NO) and combined NO and hyperoxia
will result in less pulmonary dysfunction and delay onset of
respiratory signs compared with hyperoxia-exposed newborn guinea pigs
(GPs). GPs were exposed to room air (n = 14), 95%
O2 (n = 36), 20 parts per million (ppm) NO
(n = 14), or combined 20 ppm NO and 95% O2
(NO/O2, n = 13) for up to 5 days. Data
evaluated included latency interval for onset of respiratory distress,
pressure volume curves, lung histology, and bronchoalveolar lavage
(BAL) polymorphonuclear cells (PMNs), proteolytic activity, and total
protein. NO-exposed GPs did not develop respiratory distress and had no
evidence of pulmonary dysfunction. O2-exposed GPs developed
respiratory distress after 1-5 days (median 4.0) vs. 3-5 days
(median 5.0) for NO/O2 exposure (P < 0.05). BAL from O2-exposed GPs showed increased PMNs
compared with NO/O2-exposed GPs. O2- and
NO/O2-exposed GPs had comparable reduced lung volumes, lung
histology, and increased BAL proteinase activity and total protein. In
summary 1) O2 exposure resulted in multiple
measures of pulmonary dysfunction in newborn GPs, 2) 5-day
exposure to NO produced no noticeable respiratory effects and pulmonary
dysfunction, and 3) short-term exposure (
5 days) to
NO/O2 delayed onset of respiratory distress and neither
exacerbated nor attenuated pulmonary dysfunction compared with
O2 exposure alone.
proteolytic enzyme; proteinase; combined nitric oxide and hyperoxia; pulmonary function
This article has been cited by other articles:
![]() |
A. M. Kunig, V. Balasubramaniam, N. E. Markham, G. Seedorf, J. Gien, and S. H. Abman Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1068 - L1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kunig, V. Balasubramaniam, N. E. Markham, D. Morgan, G. Montgomery, T. R. Grover, and S. H. Abman Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L529 - L535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dauger, L. Ferkdadji, G. Saumon, G. Vardon, M. Peuchmaur, C. Gaultier, and J. Gallego Neonatal Exposure to 65% Oxygen Durably Impairs Lung Architecture and Breathing Pattern in Adult Mice Chest, February 1, 2003; 123(2): 530 - 538. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |